Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Koichi Suyama"'
Autor:
Kohji Takemura, Taro Yamanaka, Michikata Hayashida, Rika Kizawa, Takeshi Yamaguchi, Yuko Tanabe, Kazushige Sakaguchi, Koichi Suyama, Shinji Urakami, Yuji Miura
Publikováno v:
IJU Case Reports, Vol 6, Iss 2, Pp 144-146 (2023)
Introduction The peripheral nervous system is one of the target organs of immune‐related adverse events. Peripheral facial nerve palsy, also called Bell's palsy, which is induced by immune checkpoint inhibitors, is quite rare, and its clinical feat
Externí odkaz:
https://doaj.org/article/d94ced95eeca4d9aac1081a55a03edb0
Autor:
Toshimi Takano, Ayako Matsuda, Noriko Ishizuka, Yukinori Ozaki, Koichi Suyama, Yuko Tanabe, Yuji Miura, Eisuke Matsushima
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background A self-help workbook is expected to support cancer patients to cope with physical and psychosocial distress, to facilitate communication with medical staff, and to improve quality of life (QOL). We conducted a randomized controlle
Externí odkaz:
https://doaj.org/article/3037d85933bc4f2785afcbd447b022b5
Autor:
Koichi Suyama, Masafumi Ikeda, Eiichiro Suzuki, Motohiro Kojima, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Takuji Okusaka, Junji Furuse
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 3, Pp 531-537 (2013)
The tumor shrinkage effect of gemcitabine is considered to be limited in cases of advanced gallbladder cancer, and there are few reports of complete response to gemcitabine therapy in patients with this cancer. Therefore, the treatment continuation s
Externí odkaz:
https://doaj.org/article/0207c8cee00245f8971c82745cfbcd95
Autor:
Yuji Miura, Koichi Suyama, Akihiko Shimomura, Jimpei Miyakawa, Hiroki Kobayashi, Akiyoshi Uki, Toshikazu Okaneya, Toshimi Takano
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 2, Pp 320-324 (2013)
Background: Everolimus, a potent mammalian target of rapamycin (mTOR) inhibitor, has shown anticancer activity against various types of cancer, including renal cell carcinoma (RCC); however, little information is available on the efficacy and safety
Externí odkaz:
https://doaj.org/article/516fedc4832843e08410aea3dc3b3f2f
Autor:
Koichi Suyama, Yuji Miura
Publikováno v:
International Journal of Clinical Oncology. 28:637-643
Autor:
Genki Watanabe, Yoshihiro Mise, Masaru Oba, Akio Saiura, Yosuke Inoue, Yu Takahashi, Yoji Kishi, Koichi Suyama, Tadatoshi Takayama, Tamaki Noie, Yujiro Nishioka, Nobuhisa Akamatsu, Junichi Arita, Norihiro Kokudo, Kiyoshi Hasegawa
Publikováno v:
HPB. 24:1245-1251
The effect of bevacizumab plus mFOLFOX6 on downsizing of liver metastases for curative resection has not been well assessed for patients with advanced colorectal liver metastases (CRLMs). This multicenter phase II trial aimed to examine the efficacy
Autor:
Haruka Ozaki, Kohji Takemura, Rika Kizawa, Takeshi Yamaguchi, Chinatsu Komiyama, Masato Tachi, Hirotaka Maruno, Yuko Tanabe, Koichi Suyama, Yuji Miura
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 21, p3163-3166, 4p
Autor:
HARUKA KONO, TARO YAMANAKA, YUKI NISHIHARA, KENJI TOMIZAWA, RIKA KIZAWA, TAKESHI YAMAGUCHI, YUKO TANABE, SHUICHIRO MATOBA, HIROYA KUROYANAGI, KOICHI SUYAMA, YUJI MIURA
Publikováno v:
Cancer Diagnosis & Prognosis; Sep/Oct2023, Vol. 3 Issue 5, p605-608, 4p
Autor:
Chihiro, Kondoh, Kenji, Ishikura, Satoko, Ichioka, Kenji, Omae, Yusuke, Okuda, Kenichiro, Koitabashi, Akira, Sasaki, Koichi, Suyama, Masahiko, Tanizawa, Takuro, Mizukami, Yugo, Shibagaki, Sumio, Hirata, Yuichi, Ando, Kengo, Furuichi, Hiroyuki, Nishiyama, Takeshi, Matsubara, Junichi, Hoshino, Motoko, Yanagita
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(11)
Chronic kidney disease(CKD)associated with cancer and its treatment affects life after cancer treatment. There is inconclusive opinion on whether CKD treatment in survivors after cancer treatment needs special care differently than in the general pop
Autor:
Rinka Miura, Koichi Suyama
Publikováno v:
2022 61st Annual Conference of the Society of Instrument and Control Engineers (SICE).